Hummingbird Bioscience Appoints Renowned Scientist and Medical Oncologist Dr. Thomas J. Lynch to its Board of Directors

HOUSTON and SINGAPORE, July 26, 2021 -- (Healthcare Sales & Marketing Network) -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced that internation... Biopharmaceuticals, Oncology, Personnel Hummingbird Bioscience, Rational Antibody Discovery
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news